Chinese medicament for treating osteoproliferation
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A technology of bone hyperplasia and traditional Chinese medicine, which is applied in bone diseases, drug combinations, medical formulas, etc., can solve the problems of strong drug dependence, temporary cure but not the root cause, and large side effects. Effect
Inactive Publication Date: 2010-10-20
张毅
View PDF0 Cites 2 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
At present, there are many types of traditional Chinese medicines for the treatment of hyperosteogeny, but they treat the symptoms but not the root cause. Western medicines have large side effects, are highly dependent on medicines, and are expensive.
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0007] A traditional Chinese medicine for treating hyperosteogeny, comprising the following active ingredients by weight:
[0008] Codonopsis 15 parts, Ligustrum lucidum 12 parts, Mildewia 7 parts, Mountain bark 10 parts, Gale medicine 5 parts, Licorice 6 parts, Nixie 4 parts, Musk 6 parts, Myrrh 8 parts, Radix Paeoniae Rubra 3 parts, Willow 2 parts of root, 9 parts of trigonum, 7 parts of Panax notoginseng powder, 4 parts of Aconitum aconitum, and 8 parts of cinnamon.
Embodiment 2
[0010] A traditional Chinese medicine for treating hyperosteogeny, comprising the following active ingredients by weight:
[0011] Codonopsis 19 parts, Ligustrum lucidum 16 parts, Miltonia 10 parts, Mountain bark grass 15 parts, Gale medicine 11 parts, Licorice 9 parts, Niu Xi 7 parts, Musk 9 parts, Myrrh 13 parts, Radix Paeoniae Rubra 6 parts, Willow 3 parts of root, 12 parts of trigonum, 10 parts of Panax notoginseng powder, 6 parts of Aconitum aconiti, and 10 parts of cinnamon.
Embodiment 3
[0013] A traditional Chinese medicine for treating hyperosteogeny, comprising the following active ingredients by weight:
[0014] Codonopsis 23 parts, Ligustrum lucidum 20 parts, Caulis Spatholobus 12 parts, Shanpi grass 20 parts, Dafeng medicine 18 parts, licorice 12 parts, Niu Xi 10 parts, musk 12 parts, myrrh 18 parts, red peony 8 parts, willow 5 parts of root, 16 parts of trigonium, 14 parts of Panax notoginseng powder, 8 parts of Aconitum aconiti, and 12 parts of cinnamon.
[0015] The traditional Chinese medicine for treating hyperosteogeny of the invention has short course of treatment, no toxic and side effects, long-lasting medicinal property, 80% cure rate, and simple and scientific preparation method.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The invention relates to a Chinese medicament for treating osteoproliferation, and belongs to the technical field of Chinese medicaments. The Chinese medicament for treating the osteoproliferation comprises the following components in part by weight: 15 to 23 parts of szechwon tangshen root, 12 to 20 parts of glossy privet fruit, 7 to 12 parts of suberect spatholobus stem, 10 to 20 parts of hairy mussaenda, 5 to 18 parts of callicarpa longissima, 6 to 12 parts of liquorice root, 4 to 10 parts of achyranthis bidentatae, 6 to 12 parts of musk, 8 to 18 parts of myrrh, 3 to 8 parts of red paeony root, 2 to 5 parts of wing nut root, 9 to 16 parts of common burreed rhizome, 7 to 14 parts of notoginseng root powder, 4 to 8 parts of kusnezoff monkshood root and 8 to 12 parts of cassia bark. The Chinese medicament for treating the osteoproliferation has the advantages of short course of treatment, no toxic or side effect, lasting medicinal properties, 80 percent of cure rate and simple and scientific preparation method.
Description
technical field [0001] The invention relates to a traditional Chinese medicine for treating hyperosteogeny, belonging to the technical field of traditional Chinese medicines. Background technique [0002] Osteoarthritis is a disease that commonly occurs in middle-aged and elderly people. In mild cases, it is unbearably painful, and in severe cases, it can lead to physical deformities or paralysis. At present, there are many types of Chinese medicines for the treatment of hyperosteogeny, but they treat the symptoms but not the root cause, and Western medicines have large side effects, are highly dependent on medicines, and are expensive. Contents of the invention [0003] The object of the present invention is to provide a traditional Chinese medicine for treating hyperosteogeny with short course of treatment, no toxic and side effects, long-lasting medicinal properties and obvious curative effect. [0004] A traditional Chinese medicine for treating hyperosteogeny, the co...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more 
Login to view more